Neurology ReviewsMultiple sclerosis prodrome holds promise of earlier diagnosisSeptember 14, 2020Multiple Sclerosis
Neurology ReviewsHigh plasma GFAP level predicts disability accumulation in secondary progressive MSSeptember 14, 2020Multiple Sclerosis
Neurology ReviewsApp for MS aims to capture elusive signals of progressionSeptember 12, 2020Multiple Sclerosis
Neurology ReviewsSatralizumab reduces risk of severe NMOSD relapseSeptember 12, 2020Multiple Sclerosis
Neurology ReviewsCardiovascular risk factors linked to brain atrophy in MSSeptember 12, 2020Multiple Sclerosis
Neurology ReviewsLessons for patients with MS and COVID-19September 12, 2020Multiple SclerosisCOVID-19 Updates
Neurology ReviewsExposure to DMT may delay disability accumulation in primary progressive MSSeptember 11, 2020Multiple Sclerosis
Neurology ReviewsIn MS, serious adverse effects are more common in rituximab versus ocrelizumabSeptember 11, 2020Multiple Sclerosis
Neurology ReviewsSmoking increases risk of high plasma NfL levels in patients with MSSeptember 11, 2020Multiple Sclerosis
Neurology ReviewsLowering rituximab dose in patients with MS proves safe and effectiveSeptember 9, 2020Multiple Sclerosis
Neurology ReviewsTNF inhibitors linked to inflammatory CNS eventsAugust 25, 2020Rare DiseasesMultiple Sclerosis
Neurology ReviewsFDA approves ofatumumab (Kesimpta) for relapsing forms of MSAugust 21, 2020Multiple Sclerosis
Neurology ReviewsCMSC MRI guidelines evolve into international consensus protocolJune 19, 2020Multiple Sclerosis
